Rite Aid Corporation

0.65
-0.13 (-16.59%)
At close: Oct 13, 2023, 8:00 PM
0.61
-5.58%
Pre-market: Oct 16, 2023, 08:03 AM EDT

Company Description

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States.

The company operates through two segments, Retail Pharmacy and Pharmacy Services.

The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line.

It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects.

In addition, this segment offers healthcare coaching and disease management services to health plans and employers.

The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups.

This segment serves health plans, commercial employers, labor groups, and state and local governments.

As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states.

Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

Rite Aid Corporation
Rite Aid Corporation logo
Country United States
IPO Date Mar 17, 1980
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 47,000
CEO Elizabeth H. Burr

Contact Details

Address:
1200 Intrepid Avenue
Philadelphia, Pennsylvania
United States
Website https://www.riteaid.com

Stock Details

Ticker Symbol RAD
Exchange NYSE
Fiscal Year March - February
Reporting Currency USD
CIK Code 0000084129
CUSIP Number 767754872
ISIN Number US7677548726
Employer ID 23-1614034
SIC Code 5912

Key Executives

Name Position
Elizabeth H. Burr Interim Chief Executive Officer & Director
Heyward Rutledge Donigan B.A. Pres, Chief Executive Officer & Director
Matthew C. Schroeder Chief Financial Officer & Executive Vice President
Paul D. Gilbert Executive Vice President, Gen. Counsel, Chief Legal Officer & Corporation Sec.
Thomas J. Sabatino Jr. Executive Vice President & Chief Legal Officer
Angele Robinson-Gaylord Senior Vice President of Store Devel.
Brian T. Hoover Chief Accounting Officer & Senior Vice President
Byron Purcell Vice President of Investor Relations & Treasurer
Christopher S. Hall Senior Vice President of Pharmacy Services
Daniel Miller Senior Vice President of Pharmacy Regulatory Affairs
Frank G. Vitrano Chief Strategic Bus. Devel. Officer
Jeanniey Walden Senior Vice President & CMO
Jessica Kazmaier Executive Vice President & Chief HR Officer
Joy Errico Seusing Senior Vice President & Chief Communications Officer
Justin L. Mennen Executive Vice President and Chief Technology & Digital Officer
Karen Lesley Staniforth Senior Vice President of Clinical Pharmacy Services & Chief Pharmacy Officer
Mark Kramer Senior Vice President of NY Metro Division
Scott Bernard Senior Vice President of Eastern Division
Steve Bixler Chief Accounting Officer
Steven K. Bixler Chief Accounting Officer & Senior Vice President

Latest SEC Filings

Date Type Title
Mar 03, 2025 15-12G Filing
Sep 12, 2024 SC 13D Filing
Sep 09, 2024 SC 13D Filing
Sep 09, 2024 SC 13D Filing
Sep 09, 2024 3 Filing
Sep 09, 2024 SC 13D Filing
Sep 09, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Sep 09, 2024 SC 13D Filing
Aug 30, 2024 SEC STAFF ACTION Filing
Aug 30, 2024 T-3/A [Amend] Filing